Gobin, J.M., Gao, J., Rey, V. et al. Proteomics analysis of human mesenchymal stromal/stem cell sarcomagenesis model identifies ALDH1A3 and CD99 as potential targets in the transformation process. BMC Biol 24, 32 (2026). https://doi.org/10.1186/s12915-025-02498-z La publicación BMC Biology se ha hecho eco del trabajo del Grupo de Sarcomas y Terapias Experimentales del IUOPA con la

Murillo, D., Domínguez-Jurado, E., Huergo, C., Gallego, B., Díez, P., Ferreras, A., … Rodríguez, R. (2026). Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma. Drug Delivery, 33(1). https://doi.org/10.1080/10717544.2026.2671485 The journal Drug Delivery has highlighted the work of the  IUOPA's  Sarcomas and experimental therapies Research Team. Check the publication at the

Viernes 12 de junio de 2026 | 13:30h Ponente: Mª Mar Rodríguez Santamaría Grupo de Investigación: TEL Bioterio Título: Bienestar animal en la práctica: Alternativas en la identificación y genotipado. Mejoras en

La premio Nobel Emmanuelle Charpentier presentó su trabajo sobre la tecnología de edición genética CRISPR/Cas9 ante más de un centenar de personas en el Auditorio Príncipe Felipe. La conferencia se enmarca dentro de los actos por el nombramiento de la bioquímica como Doctora Honoris Causa de la Universidad de Oviedo (iuopa), a propuesta

David Klenerman, Shankar Balasubramanian y Pascal Mayer

El instituto asturiano organiza un foro multidisciplinar que abarca desde los fundamentos genéticos del cáncer hasta las nuevas estrategias terapéuticas Oviedo acogerá los días 13 y 14 de mayo a la...

El especialista y catedrático toma posesión este miércoles  a las 19.00h como miembro de número de la Academia, en el Paraninfo de la Universidad de Oviedo José Luis Llorente Pendás (Oviedo, 1960) dirige el área de Otorrinolaringología del Hospital Universitario Central de Asturias (HUCA) y es catedrático de la Universidad

Viernes 24 de abril de 2026 | 13:30h Ponente: Hanh Tran Grupo de Investigación: BIONUC Título: “Antiproliferative activities of myxomycete polysaccharides” Lugar: Aula E del área docente del HUCA

Lidia Sainz Ledo (Grupo de Investigación de Epigenética del Cáncer) y Jaime San Juan Guardado (Grupo de Investigación de Tumores Raros), son los ganadores del II Minicongreso de Estudiantes del Progra...

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

About the IV IUOPA International Symposium   In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances in understanding the basic biology of tumors, as well as the genetic and epigenetic alterations they contain, have allowed targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types. These developments, together with the increasingly refined integration of multi-omics data, are driving precision medicine forward. Symposium Highlights Focus Areas: - Current advances in basic, translational, and clinical oncology research. - Development and impact of targeted therapies in the post-genomic era. - Integration of multi-omics data to accelerate precision medicine. - Immunotherapy progress and relevance for tumors with limited options. - Opportunities for researcher collaboration and synergy building. Goal of the Symposium This Symposium will highlight the most current advances in oncology research and offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Jurado A, Gómez-Cambronero CC, Rodríguez A, Lopez D, García P, Fernández L. Int J Antimicrob Agents. 2026 Feb 27:107755. doi: 10.1016/j.ijantimicag.2026.107755. Online ahead of print. PMID: 41765188 Free article. The work of the Dairy Safe Group (IPLA-CSIC) and the Epigenetic Cancer Research Team (IUOPA) has been highlighted, with the participation of Carlos Colmenero

  About the IV IUOPA International Symposium In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances that have been generated in the knowledge of the basic biology of tumors and the genetic and epigenetic alterations they contain have allowed the development of targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types, and their relevance for the treatment of tumors with scarce therapeutical options is expected to grow in the coming years. All these developments, together with the increasingly refined integration of multi-omics data, are driving forward precision medicine, opening new frontiers, and accelerating the translation of knowledge from the laboratory to the patient. Symposium Highlights This Symposium will highlight current advances in basic, translational, and clinical research, and will offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.

Viernes 10 de abril de 2026 | 13:30h Ponente: Francisco Rodriguez Grupo de Investigación: Unidad de transgénicos (IUOPA) Título: “Cartera de Servicios de la Unidad de Transgénicos” Lugar: Sala de Grados Dpto. Bioquímica de la Universidad de Oviedo

  About the IV IUOPA International Symposium In the framework of the 25th anniversary of the University Institute of Oncology of the Principality of Asturias (IUOPA), we celebrate the IV Molecular Oncology Symposium, a key event that commemorates our trajectory of excellence in oncological research. In recent years of the post-genomic era, the advances that have been generated in the knowledge of the basic biology of tumors and the genetic and epigenetic alterations they contain have allowed the development of targeted therapy to continue progressing continuously. Additionally, recent advances in immunotherapy have transformed the management and prognosis of numerous tumor types, and their relevance for the treatment of tumors with scarce therapeutical options is expected to grow in the coming years. All these developments, together with the increasingly refined integration of multi-omics data, are driving forward precision medicine, opening new frontiers, and accelerating the translation of knowledge from the laboratory to the patient. Symposium Highlights This Symposium will highlight current advances in basic, translational, and clinical research, and will offer an invaluable opportunity for researchers to interact and build synergies toward the common goal of advancing cancer research.